Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Gossamer Bio Inc
GOSS

Buy GOSS Stock

GOSS
See GOSS stock price and Buy/Sell Gossamer Bio Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
GOSS

Gossamer Bio Inc (GOSS)

About Gossamer Bio Inc (GOSS)

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 25, 2015 and is headqua...Read more
Market Cap
$1.07B
1 Year High
$14.30
Volume
782.79k
1 Year Low
$5.64
Price to Earnings Ratio
Open
$13.44
Dividend Rate
High
$13.96
Dividend Yield
Low
$13.35

Community

People who own or watch GOSS stock

GOSS Stock News

GOSS stock rating

What analysts recommend for GOSS stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1.2

GOSS price target

What analysts think GOSS will be worth
Low $5.64
High $15.78
Current $13.87
Target $15.78

Events

List of events that could affect GOSS stock.
09Aug

Earnings data Q2 2022

08Nov

Earnings data Q3 2022

GOSS earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.27
-0.54
-0.8
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022

Expected EPS
Q3 2022
-$0.66
Actual EPS
Q3 2022

Buy GOSS Stock

GOSS
See GOSS stock price and Buy/Sell Gossamer Bio Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch GOSS stock
  • bossbabe22 avatar
  • raspopoj avatar
  • cuinvest2020 avatar
  • ngir9 avatar
  • Tyler09420 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.